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Abstract The SNARE hypothesis proposes that specificity of 
exocytosis is regulated by the appropriate interactions between 
the vesicle (v-) SNARE and the target membrane (t-) SNAREs. 
We show here that pancreatic acinar cells express the SNAP-25 
t-SNARE homolog SNAP-23, and find that this t-SNARE is 
most highly concentrated on the basolateral plasma membrane 
while being expressed below detectable levels in endocrine islets 
within the same tissue. This is the first localization of SNAP-23 
within a polarized tissue and suggests that this t-SNAREs may 
interact with syntaxin-4 to mediate basolateral secretion. 
© 1997 Federation of European Biochemical Societies. 
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I. Introduction 
The pancreatic acinar cell has long been used as  model 
cell type for the study of exocytosis in non-excitable cells [1]. 
Through intensive study, the kinetics and morphology of 
complex constitutive and regulated exocytotic pathways have 
been defined in these highly polarized cells [2]. Regulated exo- 
cytosis of zymogen granules (ZG) 1 in response to low, phys- 
iologic concentrations of secretagogues, occurs at a limited 
apical portion of the acinar cell, which constitutes only 5- 
10% of the total PM surface [1,3]. Enzymatic ZG contents 
are then delivered to the collecting ducts of the pancreas 
and subsequently emptied into the intestinal lumen to digest 
nutrients. In contrast, exposure of acinar cells to supraphysio- 
logic secretagogue concentrations either in vitro or in vivo 
appears to cause a blockade of apical exocytosis, and aberrant 
ZG fusion events including fusion with the basolateral plasma 
membrane [4]. In vivo, this basolateral ZG secretion results in 
experimental conditions which appear analogous to clinical 
pancreatitis [4] where serum levels of pancreatic enzymes are 
elevated. However, the mechanisms controlling normal exo- 
crine secretion, and their possible dysfunction during pancrea- 
titis, remain to be determined. 
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Recent studies by us and others suggest hat regulation of 
ZG fusion may follow the same basic principles a described 
in the SNARE hypothesis. This general model was derived to 
explain mechanisms controlling neurotransmitter r lease, and 
extrapolated to cover most membrane transport processes in 
virtually all cells [5]. The SNARE hypothesis predicts that 
cytosolic NEM-sensitive factors (NSF) and soluble NSF at- 
tachment proteins (SNAPs), bind to SNAP receptors 
(SNAREs), located on the donor vesicle (v-SNARE) and on 
the target membrane (t-SNAREs), to mediate the docking and 
fusion of the two membranes [5]. In the nervous system the 
vesicle associated membrane protein (VAMP) on the synaptic 
vesicle, along with syntaxin-1 and synaptosomal ssociated 
membrane protein of 25 kDa (SNAP-25) on the synaptic plas- 
ma membrane, form a stable complex which acts as the re- 
ceptor (SNARE) for the soluble factors (reviewed in [6]). It is 
hypothesized that specific v- and t-SNARE combinations may 
control the accuracy of vesicle-target membrane interactions. 
The presence of multiple isoforms of VAMP [7] and syntaxin 
proteins [8], and the specificity of their interactions [9], sup- 
port this tenet. However, SNAP-25 is expressed predomi- 
nantly in the nervous system and in neuroendocrine cells 
[10] leaving non-neural cells without a critical SNARE com- 
ponent. Recently, Ravichandran et al. [11] reported the cDNA 
cloning of a novel isoform of SNAP-25, called SNAP-23, 
which is broadly expressed in non-neuronal tissues, including 
the pancreas. Antibodies pecific for SNAP-23 detect a single 
protein species associated with the plasma membrane which is 
abundant in most non-neural but not neural cells [12]. This 
identification provides a complete cassette of SNARE proteins 
in virtually all cell types. 
To determine if exocrine granule secretion is controlled by 
mechanisms similar to those involved in neurotransmitter r -
lease, we began to search for expression of SNARE homologs 
in pancreatic acinar cells. Initially we demonstrated that 
VAMP isoform-2 was an integral component of the zymogen 
granule membrane and cleavage of this protein by tetanus 
toxin resulted in inhibition of calcium-evoked digestive en- 
zyme secretion [13,14]. More recently we have demonstrated 
that acinar cells express four isoforms of syntaxin with syn- 
taxin isoform-2 restricted to the apical plasma membrane, 
syntaxin-3 on the zymogen granule (ZG), and syntaxin-4 on 
the basolateral plasma membrane of the pancreatic acinar cell 
[15]. Taken in the context of the SNARE hypothesis, their 
restricted appearance at these membrane compartments indi- 
cates that each of these syntaxins may serve as a distinct 
exocytotic target for each site [6]. 
In the present study, we demonstrate hat acinar cells also 
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express SNAP-23. Using an affinity purified antibody directed 
to the C-terminus of SNAP-23 [12], we show that SNAP-23, 
but not SNAP-25, can be detected in the acinar cells while 
endocrine cells of the pancreas express SNAP-25 predomi- 
nantly. We also show that SNAP-23, like syntaxin-4, is pre- 
dominantly localized to the basolateral plasma membrane of 
the acinar cell. The basolateral location of SNAP-23, along 
with that of syntaxin-4, suggests that these proteins do not 
participate in apical secretion, but they may be involved in 
normal or aberrant secretory events occurring at the basolat- 
eral surface. 
2. Materials and methods 
2.1. Antibody generation 
Rabbit polyclonal antibodies to VAMP-2, syntaxins-2 through -4 
and SNAP-23 were generated, subjected to affinity purification and 
their specificity validated as we have previously reported [12 15]. 
Anti-SNAP-23 specific antibody which recognizes rodent and human 
forms of the protein was generated against a peptide corresponding 
to the carboxyl-terminal residues 200-211 of SNAP-23, called 
c~SN23.C12, and affinity purified on columns to which the peptide 
had been coupled [12]. An antibody raised to the amino-terminus of
murine SNAP-23 (also called syndet) [16] was kindly provided by G. 
Baldini. Antibody raised against SNAP-25, kindly provided by M.K. 
Bennett, was generated against the bacterially expressed full length 
fusion protein of SNAP-25 and affinity purified using full length fu- 
sion protein immobilized on Affigel beads (Bio-Rad, Richmond, CA). 
The specificity of these antibodies was determined by immunoblotting 
against he recombinant full length fusion proteins and against native 
tissues (see Figs. 1 3) which showed that while the SNAP-23 antibody 
is specific only for SNAP-23, the SNAP-25 antibody cross-reacts with 
both SNAP-23 and SNAP-25. 
2.2. Subcellular membrane preparations and immunoblotting 
Pancreatic acinar plasma membranes were prepared from excised 
pancreata of Sprague-Dawley rats (250-300 g) made diabetic, as de- 
scribed [13-15], by treatment with streptozotocin which obliterates ~- 
cells. Total membranes were prepared from 3T3-LI fibroblasts as 
previously reported [12]. SDS-PAGE and immunoblots were per- 
formed as described [13] using primary antibodies diluted to 1:1000. 
Detection of the antigen on the blot was by enhanced chemilumines- 
cence (ECL, Amersham Corp.). Specificity was determined by prein- 
cubating the antibodies with 10 M excess (1 Ixg/ml) of full length 
recombinant fusion protein of the appropriate isoform for 1 h at 
room temperature prior to use as in Fig. 1. 
2.3. lmmunofluoreseenee confi~cal microscopy 
These studies were performed as previously described [14,15]. 
Briefly, pancreata from a diabetic or normal rat that have been per- 
fused in vivo with 4% paraformaldehyde in physiological saline and 
frozen in liquid nitrogen, were embedded in Tissue Tek OCT. 5 ~tm 
cryostat sections were generated, rinsed in PBS and postfixed in 4% 
paraformaldehyde, rinsed again with PBS, and then blocked with 5% 
normal goat serum with 0.1% saponin for 30 min. The tissue on the 
glass slides was then incubated at room temperature for l h with the 
primary antibodies: rabbit anti-SNAP-23 (1:50), rabbit anti-SNAP-25 
(1:50), guinea pig anti-insulin (1:100, a gift from R.A. Pedersen, Uni- 
versity of British Columbia, Vancouver, Canada). Specificity was de- 
termined by preincubation of the primary antibody with 10 M excess 
(20 p-g/ml) of full length recombinant fusion proteins of the appropri- 
ate isoforms for 1 h at room temperature prior to use. These were 
then rinsed with 0.1% saponin, and then treated with appropriate 
FITC- or rhodamine-labeled secondary antibody (1 h, room temper- 
ature): goat anti-rabbit (1:500) and goat anti-guinea pig (1:500). 
Phalloidin conjugated to FITC (Molecular Probes, Eugene, OR) 
was added during the secondary antibody step at 1 U/slide. The slides 
were then mounted with fading retarder; 0.1% p-Phenylenediamine  
glycerol, and examined using a laser scanning confocal imaging sys- 
tem (Carl Zeiss, Thornwood, NY). 
m Anti-SNAP-23 
~ Anti-SNAP-23 + GST-SNAP-25 
Anti-SNAP-23 + GST-SNAP-23 
- Anti-SNAP-25 
Anti-SNAP-25 + GST-SNAP-23 
Anti-SNAP-25 + GST-SNAP-25 
Fig. 1. SNAP-23 is present on pancreatic acinar plasma membranes 
and zymogen granule membranes. Highly purified pancreatic acinar 
plasma membranes (PM, 10 p-g of protein/lane) from diabetic (strep- 
tozotocin-treated) rats, crude brain homogenates (rat brain, 5 ~tg of 
protein/lane) and 3T3-L1 fibroblast microsomes (3T3-LI, 10 p-g of 
protein/lane) were prepared, electrophoresed on a 15% SDS-poly- 
acrylamide gel and blotted on Immobilon-P lransfer membranes 
(Millipore) as described in Section 2. These were then immunoblot- 
ted with: top row, SNAP-23 antibody; second row, SNAP-23 anti- 
body preincubated with GST-SNAP-25 (1 ~tg); l~hird row, SNAP-23 
antibody preincubated with GST-SNAP-23 (1 p,g); fourth row, 
SNAP-25 antibody; fifth row, SNAP-25 antibody preincubated with 
GST-SNAP-23; and bottom row, SNAP-25 aniibody preincubated 
with GST-SNAP-25. 
3. Results 
3.1. SNAP-23 is present in pancreatic acinar cell membranes 
To determine the presence and subcellular distribution of 
SNAP-23 and/or SNAP-25 immunoreactive proteins in the 
pancreatic acinar cell, we isolated preparations of purified 
pancreatic acinar PM for immunoblot analyses (Fig. 1). To 
avoid possible contamination with islet membranes which we 
[17] and others [18] have reported to be abundant in SNAP- 
25, membranes were isolated from streptozotocin-treated rats 
as previously described [13-15]. These were then compared to 
a homogenate of rat brain, which is abundant in SNAP-25 
[19], and 3T3-LI fibroblast otal membranes, which are abun- 
dant in SNAP-23 [12]. The top row shows that SNAP-23. 
which migrated at about 30 kDa, is abundant in both pancre- 
atic PMs and the 3T3-L1 fibroblast membranes, but is virtu- 
ally absent in the rat brain. The SNAP-23 signal was not 
affected by preincubation with excess GST-SNAP-25 (1 ~tg) 
(second row) but was blocked when preincubated with GST- 
SNAP-23 (third row), confirming the specificity of the SNAP- 
23 antibody. The same results were obtained with the anti- 
syndet/SNAP-23 antibody raised to the amino-terminus of 
this protein [16] (data not shown). The SNAP-25 antibody 
gave a strong immunoreactive signal in the rat brain and a 
weaker signal in the pancreatic PM and 3T3-L1 membranes 
(fourth row). GST-SNAP-23 had no effect on the SNAP-25 
signal in rat brain but significantly inhibited the signal in the 
pancreatic membranes and 3T3-L1 membranes (row 5), 
whereas GST-SNAP-25 completely blocked all of the signals 
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Fig. 2. SNAP-23 is present in pancreatic acinar cell and SNAP-25 is present in pancreatic islets. Laser sc nning confocal microscopy was used 
to distinguish the distribution of SNAP-25 (in a) and SNAP-23 (in c) in normal (non-diabetic) pancreatic tissue from a rat. These tissue s c- 
tions were double labeled with guinea pig anti-insulin antibody to indicate the location of the islets (in b and d). 
from this antibody (row 6). Furthermore, a monoclonal anti- 
body (SMI 81, Sternberger Monoclonal Inc.) which recognizes 
brain and islet SNAP-25 failed to recognize the acinar iso- 
form. However, this antibody gave a strong cross-reaction 
to high molecular weight material within the ZG (data not 
shown) and was not used further. Together, our data indicate 
that the SNAP-25 immunoreactivity detected in the pancreatic 
PM and 3T3-L1 membranes, was actually SNAP-23 to which 
the SNAP-25 antibody cross-reacted. 
3.2. SNA P-23 and SNAP-25 are present in pancreatic acinar 
cells and islets, respectively 
The pancreas provides an ideal opportunity to compare the 
endocrine and exocrine tissues ide-by-side for the presence of 
SNAP-25 and SNAP-23 (Fig. 2). We therefore performed 
double label immunofluorescence microscopy on pancreatic 
sections taken from normal (non-diabetic) rats using affinity 
purified SNAP-23 and SNAP-25 antibodies individually ong 
with antibodies pecific to rat insulin. In the islets, insulin 
(Fig. 2b) was restricted to cells in which SNAP-25 was abun- 
dant and localized to the cell membrane (Fig. 2a). In contrast, 
SNAP-23 antibody strongly stained the plasma membrane of 
every acinar cell (Fig. 2c), but minimally if at all in the insulin 
positive islets (Fig. 2d). Therefore, unlike VAMP and syntaxin 
proteins which are xpressed in both the endocrine and exo- 
crine pancreas [14,15,17], SNAP-25 and SNAP-23 appear to 
be most abundantly expressed in pancreatic endocrine and 
exocrine cells, respectively. 
C 
t 
i 
b7 
H. E Gaisano et aL/FEBS Letters 414 (1997) 298 302 301 
Fig. 3. Subcellular location of SNAP-23 to the basolateral plasma membrane of pancreatic acinar cells by laser confocal microscopy. Pancreatic 
sections from diabetic rats were labeled with either anti-SNAP-23 (a~t) or anti-SNAP-25 (e f) antibodies. Preincubation with either GST- 
SNAP-23 (c, f) or GST-SNAP-25 (d) recombinant proteins were performed prior to immunostaining to demonstrate he specifici y of he immu- 
nostaining. SNAP-25 in a nerve fiber (arrowhead in f) was not blocked by GST-SNAP-23. Double labeling with FITC-phalloidin (b) was per- 
formed to indicate the apical portion of the acinar cells (arrows in a and b). 
3.3. SNAP-23 is located on the basolateral plasma membrane 
o f  the pancreatic acinar cell 
To more precisely map the subcellular location of SNAP-23 
in acinar cells we have performed ouble label immunofluo- 
resence microscopy on sections from the pancreas of diabetic 
rats with the SNAP-25 and SNAP-23 antibodies along with 
phalloidin, which labels actin filaments near the apical surface 
of the acinar cell [15,20]. As shown in Fig. 3a, the SNAP-23 
antibody labels the basal and lateral plasma membrane of 
every acinar cell but was below detectable vels on the apical 
portions which are labeled by phalloidin (Fig. 3b). The same 
result was observed with the anti-syndet/SNAP-23 antibody 
(data not shown). The SNAP-23 signal was completely 
blocked by GST-SNAP-23 (Fig. 3c) but was not affected by 
preincubation of the antibody with GST-SNAP-25 (Fig. 3d). 
A similar pattern was detected with the SNAP-25 antibody 
(Fig. 3e) when the laser intensity was significantly increased, 
although this could not be seen at intensities used for SNAP- 
23 (See Fig. 2a). The SNAP-25 signal on the acinar cell was 
completely blocked by preincubation of the antibody with 
GST-SNAP-25 (not shown), as well as with GST-SNAP-23 
(Fig. 31"). The GST-SNAP-23, however, did not block the 
SNAP-25 signal of a nerve fiber straddling the basal surface 
of an acinus (arrowhead in f). Again, this confirms that the 
only immunoreactivity detected by the SNAP-25 antibody in 
exocrine acinar cells was SNAP-23. 
4. Discussion 
SNAP-23 is a recently described, widely expressed isoform 
of the neuronal t-SNARE SNAP-25 [11,12,16]. SNAP-23 is 
59% identical to SNAP-25 at the amino acid level and its 
mRNA and protein are expressed in on-neuronal tissues 
[11,12,16]. To determine which of these two proteins are 
present in pancreatic acinar cells, we used polyclonal antibod- 
ies specific for SNAP-25 [15,17], and SNAP-23 [12,16] in 
Western blotting and immunocytochemical studies. The anti- 
bodies raised against SNAP-25 recognized proteins in the rat 
brain, pancreatic islet, and exocrine acinar cell. However, the 
latter signal appears to be the result of cross-reaction since it 
could be fully blocked by pre-incubation of the antibodies 
with recombinant SNAP-23 proteins. In contrast, anti- 
SNAP-23 antibodies gave strong signals for acinar cell mem- 
brane preparations and little if any signal for neural mem- 
branes, and this signal was not sensitive to blocking by pre- 
incubation with GST-SNAP-25 but was eliminated by GST- 
SNAP-23. Together with a previous study which failed to 
detect SNAP-25 in the acinar cell using an antibody specific 
to the carboxyl-terminus of SNAP-25 [18], our results show 
that SNAP-23 is the predominant isoform and that SNAP-25 
is not abundantly expressed in these cells. 
The pancreas i  a tissue which allows simultaneous assess- 
ment of protein expression in both endocrine and exocrine 
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cells. We observed that SNAP-23 was expressed much more 
abundantly in the exocrine than the endocrine cells, the recip- 
rocal of the pattern seen for SNAP-25. Interestingly, the other 
SNARE proteins VAMP-2 and syntaxin-1 appear to be ex- 
pressed in both cell types [13,15,17,18] albeit at much higher 
levels in endocrine cells. This suggests that the SNAP-23/ 
SNAP-25 component of the secretory machinery may provide 
specialized features for secretion i each cell type. The nature 
of this difference will await further characterization f the 
precise role of SNAP-23 in membrane fusion. 
Within the pancreatic acinar cell, SNAP-23 is present in 
abundance on the basolateral membranes and was virtually 
absent from the apical surface. We had previously demon- 
strated that acinar cells express four isoforms of syntaxin 
and this subcellular location overlaps with distribution of syn- 
taxin-4 in acinar cells [15]. Although SNAP-23 can form bi- 
nary interactions with all four of the syntaxin isoforms in 
vitro, it is interesting to see that it co-localizes with only 
one of them, and that no co-localization was seen with the 
apically localized syntaxin-2. SNAP-23 is therefore unlikely to 
be localized solely by its association with the syntaxins, but 
whether it is targeted by association with other proteins or 
carries its own targeting signals is not known. 
The appearance of SNAP-23 at the basolateral surface rep- 
resents the first evidence for regional localization of this new 
t-SNARE isoform within polarized cells and argues that this 
protein may participate, along with syntaxin-4 and a member 
of the VAMP family to mediate basolateral membrane fusion 
events. In vitro studies have shown that VAMP-1 and VAMP- 
2 can bind to syntaxin-1 or syntaxin-4 with high affinity, but 
not with syntaxin-2 or -3, suggesting specificity of v-SNARE- 
t-SNARE interactions [9]. SNAP-25 and SNAP-23, on the 
other hand, do not appear to contribute to this specificity 
and are capable of binding to each of the syntaxin and 
VAMP isoforms [9,11]. Given the presence of VAMP-2 on 
the ZGM, a complete cassette of interacting v- and t-SNAREs 
exists for the ZG to fuse with the basolateral PM. Since this 
rarely occurs under normal circumstances, their interaction 
must be under additional levels of control. Interestingly, in 
response to high agonist concentrations, interstitial pancreati- 
tis can result from the inappropriate r lease of zymogens to 
the basolateral surfaces [4,21]. Whether such events result 
from a failure of such control mechanisms, or entry of the 
vesicles into minor constitutive exocytosis pathways operating 
through the basolateral surfaces [22] is not known. 
Finally, the location of SNAP-23 to the basolateral mem- 
branes, coupled with the observation that syntaxin isoforms 
were also distinctly localized within these cells, suggests that 
apical secretion is quite distinct from basolateral secretion. 
Since the only identified v-SNARE on the ZGM, VAMP-2, 
does not form stable complexes with the apical t-SNARE 
syntaxin-2 in vitro, it is possible that additional isoforms of 
SNAP-25 and VAMP may exist to provide a complete 
SNARE cassette for apical secretion. Alternatively, it is also 
possible that apical secretion may occur by means other than 
those explained in the SNARE hypothesis. It has been shown 
in Madin-Darby canine kidney (MDCK) cells that vesicular 
transport from the trans-Golgi network to the basolateral 
plasma membrane is dependent on NSF and ~SNAP, and is 
sensitive to tetanus and botulinum neurotoxins which cleave 
VAMP-2 [23]. In contrast, apical secretion in MDCK cells is 
independent of NSF, txSNAP and insensitive to tetanus toxin 
[23]. In our studies, we have found that while Ca2+-evoked 
amylase secretion from isolated, permeabilized acinar cells can 
be inhibited by tetanus toxin cleavage of VAMP-2, this inhib- 
ition is always partial [13]. We are currently investigating the 
possibility that the permeabilized preparation may exhibit 
both apical and basolateral secretion with only the latter being 
sensitive to tetanus toxin. If so, this may provide a valuable 
model system to examine the mechanisms controlling normal 
granule targeting specificity and to develop compounds which 
could be effective at blocking basolateral secretion events 
which may be associated with pancreatitis. More work is re- 
quired to identify the apical and vesicular p oteins responsible 
for regulated apical secretion in acinar cells. 
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